Why the study?
Does co-administration of terfenadine and ketoconazole cause QT prolongation and Torsades de Pointes?
Does co-administration of terfenadine and ketoconazole cause QT prolongation and Torsades de Pointes?
Co-administration of terfenadine and ketoconazole can lead to severe adverse cardiac events, specifically QT prolongation and symptomatic Torsades de Pointes.
Answers are grounded in this paper and cite their sources.
Raises caution for terfenadine-ketoconazole co-use; hypothesis-generating and should not yet change practice.
An episode of QT prolongation with symptomatic Torsades de Pointes is described which developed in a 22-year-old healthy female following 5 days therapy with terfenadine and ketoconazole on an ordinary dosage.
No takes yet. Share an insight, caveat, or question.
ZlMMERMANN et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: